Page 322 - ESHRE2019

POSTER VIEWING SESSION
Safety and quality of ART therapies
P-738 Impact of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) on birth defects. A systematic review and meta-analysis
F. Dieamant1,2, C.G. Petersen1,2, A.L. Mauri1,2, M. Mattila1, L.D. Vagnini2, A. Renzi2, B. Petersen1,2, C. Zamara1, J.B.A. Oliveira1,2, R.L. Baruffi1,2, J.G. Franco Jr1,2
1Centre for Human Reproduction Prof Franco Jr, Research, Ribeirao Preto, Brazil 2Paulista Center for Diagnosis Research and Training, Research, Ribeirao Preto, Brazil
P-739 Extreme mitochondrial DNA sequence divergence is tolerated in primate offspring produced by mitochondrial replacement therapy
H. Darby1, C. Van Dyken1, H. Ma1, N. Marti-Gutierrez1, A. Koski1, Y. Li1, T. Hayama1, E. Kang1,2, Y. Lee1,2, D. Liang1, R. Ahmed1, P. Amato1,3, S. Mitalipov1
1Oregon Health Science University, Center for Embryonic Cell and Gene Therapy, Portland, U.S.A. 2ASAN Medical Center, Stem Cell Center- ASAN Institute for Life Sciences, Seoul, Korea- South
3Oregon Health Science University, Division of Reproductive Endocrinology- Department of Obstetrics and Gynecology, Portland, U.S.A.
P-740 The incidence of monozygonic twins in assisted reproduction technology
X. Feng1, P. Liu1
1Center for Reproductive Medicine, Department of Obstetrics and Gynecology- Peking University Third Hospital, Beijing, China
P-741 Predictive factors for dizygotic twin pregnancies after single embryo transfer: a retrospective analysis of a large-scale nationwide database study
T. Takahashi1, I. Takehara2, K. Ota1, H. Mizunuma1, S. Nagase2
1Fukushima Medical University, Fukushima Medical Center for Children and Women, Fukushima, Japan 2Yamagata University, Obstetrics and Gynecology, Yamagata, Japan
P-742 Safety of originator follitropin alfa (GONAL-f) for fertility treatment – Frequency of OHSS and thromboembolism in the scientific literature and the Merck KGaA safety database
E. Velthuis1, J. Hubbard2, S. Longobardi3, T. D’Hooghe3
1Merck B.V., Global Patient Safety, Schiphol Rijk, The Netherlands 2EMD Serono, Research & Development Institute, Billerica, U.S.A. 3Merck KGaA, Global Medical Affairs Fertility, Darmstadt, Germany
322